Health News | Council Bluffs Injury Law News

Latest Xarelto News

The anticoagulant drug, Xarelto, has been the subject of warnings on this site on more than one occasion due to its dangerous bleeding complications with no proven antidote to date. Now reports are coming in pointing to misconduct and discrepancies carried out by Xarelto’s makers…

By Craig Kelley

/ 23 Mar 2015

Tylenol Makers Plead Guilty

Walk to your medicine cabinet and throw away all your over-the-counter drugs made by Johnson & Johnson. Does that sound alarmist? Perhaps it does, but Johnson & Johnson subsidiary (McNeil Consumer Healthcare) just pled guilty on March 10, 2015 to selling their millions of loyal…

By Craig Kelley

/ 13 Mar 2015

Xarelto: Latest News

Xarelto blood thinning medication continues to be the subject of lawsuits due to its dangerous bleeding risks, with no approved antidote to date. Janssen Pharmaceuticals (Johnson & Johnson subsidiary) and Bayer Corporation are now the subjects of consolidated lawsuits on behalf of patients injured b

By Craig Kelley

/ 5 Feb 2015

Antipsychotic Drugs and Fatal Skin Reaction

Yet another drug warning is being put out there by the U.S. Food and Drug Administration (FDA)! It seems that the anti-psychotic prescription drug, Geodon (generic ziprasidone) from Pfizer has a new drug label warning: Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS). This condition…

By Craig Kelley

/ 18 Dec 2014

The Unintended Dangers of Prescription Painkillers

Every day there are forty-six deaths in the United States attributable to a prescription overdose. In 2011 alone, 16,917 overdose deaths involved opioid pain relievers, with 31% of the deaths including benzodiazepine sedatives as well (CDC WONDER, unpublished data, 2014). In 2012, health care provid

By Craig Kelley

/ 25 Jul 2014

Severe Bleeding Risk Linked to Xarelto

One of the newest blood thinners on the market, Xarelto, has been added to the list of drugs with dangerous side effects. Xarelto was approved in 2011 as a potentially safer alternative to Warfarin, as Xarelto does not require regular blood monitoring or frequent doctor…

By Craig Kelley

/ 10 Jul 2014

Androgel: Is it worth the cardiovascular risk?

Low testosterone is a fairly common problem for many men after the age of thirty. As a man begins to lose testosterone, he can experience a number of serious health problems such as depression, a decreased libido, erections which are less pleasurable, low energy levels…

By Craig Kelley

/ 4 Jun 2014

Pradaxa: Do the Risks Outweigh the Benefits?

Stroke is the third leading cause of death in the United States and the leading cause of long term disability. Pradaxa was approved in October of 2010 in an effort to provide a safer alternative to oral warfarin, injectable low molecular weight heparin or asprin,…

By Craig Kelley

/ 20 May 2014

YAZ: Birth Control Lawsuits Suggest Stronger Warning Labels Necessary

Yaz or Yasmin has now been linked to the deaths of at least 23 Canadian women, over half of which were under the age of 26. In addition, over 600 adverse reactions to Yaz and Yasmin were reported between 2007 and February of 2013. Although…

By Craig Kelley

/ 24 Mar 2014

Pradaxa Complications Lead to Irreversible Damage

Pradaxa is a medication used to prevent stroke and blood clots in patients with atrial fibrillation. It has been widely prescribed since it’s release in 2010. Unfortunately, studies in the New England Journal of Medicine have warned that the lack of an effective treatment for…

By Craig Kelley

/ 24 Feb 2014

Johnson & Johnson: Are Patients or Profits Taking the Lead in Risperdal Lawsuits?

Over the past several years, there has been an increase in lawsuits against Johnson & Johnson for various products including NuvaRing, vaginal mesh, and even a broad recall of children’s medicines. Although each lawsuit against Johnson & Johnson has its own individual facts and considerations,…

By Craig Kelley

/ 7 Feb 2014

Lexapro Effectively Treats Depression, but Is the Cure Worse Than the Disease?

Major depressive disorder affects approximately 14.8 million American adults or about 6.7 percent of the United States population, age 18 and older (Archives of General Psychiatry, 2005 June; 62(6): 617-27). It’s not surprising that pharmaceutical antidepressants have become such a big business. U

By Craig Kelley

/ 29 Jan 2014